Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
1500 participants
INTERVENTIONAL
2019-08-09
2029-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A1: Nivolumab Monotherapy Dose 1
Nivolumab
Specified dose on specified days
A2: Nivolumab Monotherapy Dose 2
Nivolumab
Specified dose on specified days
B1: Nivolumab + Ipilimumab
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
B2: Nivolumab + Ipilimumab + Cabozantinib
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
Cabozantinib
Specified dose on specified days
B3: Nivolumab + Ipilimumab + Trametinib
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
Trametinib
Specified dose on specified days
C1: Relatlimab + Nivolumab Fixed Dose Combination Dose 1
Nivolumab + Relatlimab
Specified dose on specified days
C3: Relatlimab + Nivolumab Fixed Dose Combination Dose 2
Nivolumab + Relatlimab
Specified dose on specified days
C2: Relatlimab + Nivolumab Single Agent Vial (SAV) Dose 1
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
C4: Relatlimab + Nivolumab SAV Dose 2
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
C5: Relatlimab + Nivolumab + Ipilimumab
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
C6: Relatlimab + Nivolumab + Capecitabine
Nivolumab + Relatlimab
Specified dose on specified days
Capecitabine
Specified dose on specified days
C7: Relatlimab + Nivolumab SAV Dose 3
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
C10: Relatlimab + Nivolumab SAV Dose 4
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
C12: Relatlimab + Nivolumab SAV Dose 5
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
C8: Relatlimab + Nivolumab SAV + PDCT Dose 1
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
C9: Relatlimab + Nivolumab SAV + Bevacizumab
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
Bevacizumab
Specified dose on specified days
C11: Relatlimab + Nivolumab SAV + PDCT Dose 2
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
D1: Nivolumab + Temozolomide
Nivolumab
Specified dose on specified days
Temozolomide
Specified dose on specified days
D2: Nivolumab + Rucaparib
Nivolumab
Specified dose on specified days
Rucaparib
Specified dose on specified days
D3: Nivolumab + Daratumumab
Nivolumab
Specified dose on specified days
Daratumumab
Specified dose on specified days
D4: Nivolumab + Bevacizumab
Nivolumab
Specified dose on specified days
E1: Bevacizumab Monotherapy
Bevacizumab
Specified dose on specified days
E2: Regorafinib Monotherapy
Regorafinib
Specified dose on specified days
E4: Leucovorin + Oxaliplatin + Fluorouracil
Leucovorin
Specified dose on specified days
Fluorouracil
Specified dose on specified days
Oxaliplatin
Specified dose on specified days
E5: Enzalutamide Monotherapy
Enzalutamide
Specified dose on specified days
E6: Sunitinib Monotherapy
Sunitinib
Specified dose on specified days
E7: Rucaparib Monotherapy
Rucaparib
Specified dose on specified days
E8: Capecitabine Monotherapy
Capecitabine
Specified dose on specified days
E9: Cabozantinib Monotherapy
Cabozantinib
Specified dose on specified days
E10: Pemetrexed Monotherapy
Pemetrexed
Specified dose on specified days
E11: Pembrolizumab Monotherapy
Pembrolizumab
Specified dose on specified days
E3: Leucovorin + Fluorouracil
Leucovorin
Specified dose on specified days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
Cabozantinib
Specified dose on specified days
Trametinib
Specified dose on specified days
Relatlimab
Specified dose on specified days
Nivolumab + Relatlimab
Specified dose on specified days
Capecitabine
Specified dose on specified days
Bevacizumab
Specified dose on specified days
Temozolomide
Specified dose on specified days
Rucaparib
Specified dose on specified days
Daratumumab
Specified dose on specified days
Regorafinib
Specified dose on specified days
Leucovorin
Specified dose on specified days
Fluorouracil
Specified dose on specified days
Oxaliplatin
Specified dose on specified days
Enzalutamide
Specified dose on specified days
Sunitinib
Specified dose on specified days
Pemetrexed
Specified dose on specified days
Pembrolizumab
Specified dose on specified days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.
* On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.
* WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.
Exclusion Criteria
* Participants not receiving clinical benefit as assessed by the Investigator.
* Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Exelixis
INDUSTRY
Novartis
INDUSTRY
Clovis Oncology, Inc.
INDUSTRY
Janssen Pharmaceuticals
INDUSTRY
Bristol-Myers Squibb
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution - 0220
Huntsville, Alabama, United States
University of Arizona College of Medicine
Tucson, Arizona, United States
Innovative Clinical Research Institute
Lynwood, California, United States
Local Institution
San Francisco, California, United States
Local Institution - 0099
San Francisco, California, United States
Local Institution - 0233
Aurora, Colorado, United States
Local Institution - 0095
New Haven, Connecticut, United States
Local Institution - 0088
Washington D.C., District of Columbia, United States
Florida Cancer Affiliates
Ocala, Florida, United States
Local Institution
Orlando, Florida, United States
Local Institution - 0024
Tampa, Florida, United States
Local Institution - 0105
Chicago, Illinois, United States
Local Institution
Maywood, Illinois, United States
Local Institution - 0279
Park Ridge, Illinois, United States
Local Institution - 0186
Westwood, Kansas, United States
Local Institution - 0165
Wichita, Kansas, United States
University of Louisville-James Graham Brown Cancer Center
Louisville, Kentucky, United States
Local Institution - 0092
Baltimore, Maryland, United States
Local Institution - 0039
Boston, Massachusetts, United States
Dana_Farber Cancer Institute (DFCI)
Boston, Massachusetts, United States
Local Institution - 0081
Boston, Massachusetts, United States
Local Institution - 0143
Ann Arbor, Michigan, United States
Local Institution - 0100
Minneapolis, Minnesota, United States
Local Institution
St Louis, Missouri, United States
Local Institution - 0205
Omaha, Nebraska, United States
Local Institution - 0014
Lebanon, New Hampshire, United States
Local Institution
Albuquerque, New Mexico, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Local Institution - 0413
Mineola, New York, United States
Local Institution
New York, New York, United States
Local Institution - 0185
New York, New York, United States
Local Institution - 0202
New York, New York, United States
Local Institution
New York, New York, United States
Local Institution - 0204
Charlotte, North Carolina, United States
Local Institution - 0016
Durham, North Carolina, United States
Oncology Hematology Care
Cincinnati, Ohio, United States
Local Institution - 0408
Cincinnati, Ohio, United States
Local Institution
Cleveland, Ohio, United States
The Ohio University
Columbus, Ohio, United States
Local Institution - 0246
Tulsa, Oklahoma, United States
Local Institution - 0037
Allentown, Pennsylvania, United States
Local Institution - 0054
Easton, Pennsylvania, United States
Lancaster General Health
Lancaster, Pennsylvania, United States
Allegheny Valley Hospital
Natrona Heights, Pennsylvania, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution - 0162
Philadelphia, Pennsylvania, United States
Local Institution - 0110
Pittsburgh, Pennsylvania, United States
Local Institution - 0228
Charleston, South Carolina, United States
Local Institution
Greenville, South Carolina, United States
Local Institution
Chattanooga, Tennessee, United States
Tennesse Oncology
Nashville, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Local Institution
Dallas, Texas, United States
Local Institution - 0364
Houston, Texas, United States
Local Institution - 0055
Salt Lake City, Utah, United States
Local Institution
Charlottesville, Virginia, United States
Public Hospital of King County District 1 Valley Medical Center
Renton, Washington, United States
Local Institution - 0065
Madison, Wisconsin, United States
Local Institution - 0124
Madison, Wisconsin, United States
Local Institution - 0199
Berazategui, Buenos Aires, Argentina
Local Institution - 0415
Río Cuarto, Córdoba Province, Argentina
Centro de Investigaciones Clinicas. Clinica Viedma S.A.
Viedma, Río Negro Province, Argentina
Sanatorio Parque
Rosario, Santa Fe Province, Argentina
CAIPO Centro para la Atencion Integral del Paciente Oncologico
San Miguel de Tucumán, Tucumán Province, Argentina
Local Institution - 0191
San Miguel de Tucumán, Tucumán Province, Argentina
Local Institution - 0201
Buenos Aires, , Argentina
Instituto Fleming
Buenos Aires, , Argentina
Local Institution
CABA, , Argentina
Fundacion Richardet Longo - IONC
Córdoba, , Argentina
Local Institution - 0170
Córdoba, , Argentina
Local Institution - 0045
Coffs Harbour, New South Wales, Australia
Melanoma Institute Australia
North Sydney, New South Wales, Australia
Chris OBrien Lifehouse Hospital
Sydney, New South Wales, Australia
Local Institution - 0193
Waratah, New South Wales, Australia
Local Institution - 0208
Westmead, New South Wales, Australia
Gallipoli Medical Foundation
Greenslopes, Queensland, Australia
Local Institution - 0372
Greenslopes, Queensland, Australia
Local Institution
South Brisbane, Queensland, Australia
Tasman Oncology Research Ltd
Southport, Queensland, Australia
Local Institution
Adelaide, South Australia, Australia
Local Institution - 0196
Elizabeth Vale, South Australia, Australia
BRICC - Ballarat Health Services
Ballarat, Victoria, Australia
Local Institution - 0365
Fitzroy, Victoria, Australia
Cabrini Hospital Malvern
Malvern, Victoria, Australia
Local Institution - 0174
Murdoch, Western Australia, Australia
Local Institution - 0254
Graz, Styria, Austria
Ordensklinikum Linz GmbH Elisabethinen
Linz, Upper Austria, Austria
Allgemeines Krankenhaus Wien
Vienna, , Austria
Local Institution - 0104
Vienna, , Austria
Local Institution - 0145
Wels, , Austria
Local Institution - 0329
Brussels, , Belgium
Local Institution - 0232
Ghent, , Belgium
Local Institution - 0139
Jette, , Belgium
Local Institution - 0261
Liège, , Belgium
Local Institution - 0293
Sint-Niklaas, , Belgium
Cliniques Universitaires UCL de Mont-Godinne (CHU)
Yvoir, , Belgium
Local Institution - 0260
Belo Horizonte, Minas Gerais, Brazil
ONCOSITE - Centro de Pesquisa Clinica em Oncologia
Ijuí, Rio Grande do Sul, Brazil
Local Institution - 0379
Passo Fundo, Rio Grande do Sul, Brazil
Local Institution - 0093
Porto Alegre, Rio Grande do Sul, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Sao Lucas Da Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0399
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0264
Barretos, São Paulo, Brazil
Local Institution - 0262
São José do Rio Preto, São Paulo, Brazil
ICESP - Instituto do Cancer do Estado de Soo Paulo
São Paulo, São Paulo, Brazil
Local Institution - 0263
São Paulo, São Paulo, Brazil
Hospital Alemao Oswaldo Cruz
São Paulo, São Paulo, Brazil
Local Institution - 0266
Rio de Janeiro, , Brazil
Local Institution - 0258
Rio de Janeiro, , Brazil
Local Institution - 0340
São Paulo, , Brazil
Cross Cancer Institute
Edmonton, Alberta, Canada
Local Institution
Vancouver, British Columbia, Canada
Local Institution
Halifax, Nova Scotia, Canada
Local Institution - 0168
Oshawa, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Local Institution - 0040
Montreal, Quebec, Canada
Local Institution - 0308
Montreal, Quebec, Canada
Local Institution - 0363
Temuco, Región de la Araucanía, Chile
Local Institution - 0398
Providencia, Santiago Metropolitan, Chile
Bradford Hill Centro de Investigacion Clinica
Santiago, Santiago Metropolitan, Chile
Fundacion Arturo Lopez Perez
Santiago, Santiago Metropolitan, Chile
Local Institution
Santiago, Santiago Metropolitan, Chile
Local Institution - 0079
Viña del Mar, , Chile
Local Institution - 0169
Hefei, Anhui, China
Local Institution - 0198
Beijing, Beijing Municipality, China
Local Institution
Guangzhou, Guangdong, China
Nanfang Hospital; Southern Medical University
Guangzhou, Guangdong, China
Local Institution - 0245
Harbin, Heilongjiang, China
Harbin Medical University - Cancer Hospital
Harbin, Heilongjiang, China
Local Institution - 0160
Harbin, Heilongjiang, China
Local Institution - 0172
Changsha, Hunan, China
Xiangya Hospital Central South University
Changsha, Hunan, China
Hunan Cancer Hospital
Changsha, Hunan, China
Local Institution - 0348
Nanjing, Jiangsu, China
Jilin University (JLU) - First Affiliated Hospital - Cancer Center
Changchun, Jilin, China
Jilin Cancer Hospital
Changchun, Jilin, China
Tangdu Hospital of Fourth Military Medical University
Xi'an, Shaanxi, China
Xian International Medical Center Hospital
Xi'an, Shan3XI, China
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Fudan University - Shanghai Cancer Center FUSCC
Shanghai, Shanghai Municipality, China
Local Institution - 0278
Shanghai, Shanghai Municipality, China
Local Institution - 0325
Shanghai, Shanghai Municipality, China
Local Institution - 0188
Shanghai, Shanghai Municipality, China
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
The First Affiliated Hospital Zhejiang University (The First Hospital of Zhejiang Province)
Hangzhou, , China
Local Institution - 0390
Nanjing, , China
Local Institution - 0371
Brno, , Czechia
FNHK Klinika onkologie a radioterapie
Hradec Králové, , Czechia
Local Institution - 0150
Olomouc, , Czechia
Local Institution - 0253
Prague, , Czechia
Local Institution - 0275
Prague, , Czechia
Local Institution
Odense C, , Denmark
Local Institution
Helsinki, , Finland
Local Institution - 0006
Bordeaux, Gironde, France
CHU De Nancy Hopital De Brabois
Vandœuvre-lès-Nancy, Meurthe-Et-Moselle, France
Centre Jean Perrin
Clermont-Ferrand, , France
Local Institution - 0107
Créteil, , France
Local Institution - 0074
Dijon, , France
Centre Georges-Francois Leclerc
Dijon, , France
CHU Grenobles Alpes
La Tronche, , France
Pole Biologie Pathologie Genetique - CHU de Lille
Lille, , France
APHM - Hopital de la Timone
Marseille, , France
Local Institution - 0153
Marseille, , France
CHU Montpellier
Montpellier, , France
Local Institution
Montpellier, , France
CHU Nantes - Hotel Dieu
Nantes, , France
Local Institution - 0300
Nantes, , France
Local Institution - 0028
Paris, , France
Local Institution - 0301
Paris, , France
Local Institution - 0167
Paris, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Local Institution
Rennes, , France
CHU de Saint-Etienne - Hopital Nord
Saint-Priest-en-Jarez, , France
Hopital Foch
Suresnes, , France
Local Institution - 0156
Toulon, , France
Local Institution
Toulouse, , France
Institut Gustave Roussy
Villejuif, , France
Local Institution - 0387
Paris, Île-de-France Region, France
Local Institution - 0386
Löwenstein, Baden-Wurttemberg, Germany
Local Institution - 0276
Munich, Bavaria, Germany
Local Institution - 0332
Nuremberg, Bavaria, Germany
Evangelische Kliniken Essen Mitte. Evang. Huyssens-Stiftung Essen-Huttrop
Essen, North Rhine-Westphalia, Germany
Local Institution - 0250
Essen, North Rhine-Westphalia, Germany
Local Institution - 0375
Essen, North Rhine-Westphalia, Germany
Universitaetsklinikum Aachen
Aachen, , Germany
Local Institution - 0248
Berlin, , Germany
Local Institution - 0249
Buxtehude, , Germany
Local Institution - 0296
Cologne, , Germany
Local Institution
Cologne, , Germany
University of Freiburg
Freiburg im Breisgau, , Germany
Local Institution
Gera, , Germany
SRH Wald-Klinikum Gera GmbH
Gera, , Germany
Local Institution - 0076
Göttingen, , Germany
Local Institution
Göttingen, , Germany
Local Institution - 0241
Hamburg, , Germany
Local Institution
Heidelberg, , Germany
Thoraxklinik
Heidelberg, , Germany
Local Institution - 0342
Heidelberg, , Germany
SLK-Kliniken Heilbronn GmbH
Heilbronn, , Germany
Universitaetsklinikum Jena - Klinik und Poliklinik fuer Urologie
Jena, , Germany
Local Institution - 0288
Kassel, , Germany
Local Institution - 0072
Kiel, , Germany
Local Institution
Kiel, , Germany
Local Institution - 0298
Löwenstein, , Germany
Local Institution - 0098
Lübeck, , Germany
Local Institution - 0089
Mainz, , Germany
Local Institution
Mainz, , Germany
Local Institution - 0017
Tübingen, , Germany
Local Institution - 0277
Tübingen, , Germany
Alexandra Hospital
Athens, Attica, Greece
Local Institution - 0244
Heraklion, Crete, Greece
General Hospital of Athens Laiko
Athens, , Greece
Local Institution - 0126
Athens, , Greece
Local Institution - 0171
Athens, , Greece
Local Institution - 0042
Athens, , Greece
Local Institution - 0295
Athens, , Greece
Local Institution
Pátrai, , Greece
Local Institution - 0215
Thessaloniki, , Greece
Queen Mary Hospital
Hong Kong, , Hong Kong
Local Institution - 0290
Gyöngyössolymos, Heves County, Hungary
Local Institution - 0159
Budapest, , Hungary
Local Institution - 0226
Budapest, , Hungary
Local Institution - 0187
Debrecen, , Hungary
Local Institution - 0227
Dublin, , Ireland
Local Institution
Limerick, , Ireland
Local Institution - 0190
Haifa, , Israel
Local Institution - 0270
Jerusalem, , Israel
Local Institution
Petah Tikva, , Israel
Sheba Medical Center
Ramat Gan, , Israel
Local Institution - 0350
Tiqwa, , Israel
IRCCS - Istituto Scientifico Romagnolo per lo Studio dei Tumori - Dino Amadori - Srl
Meldola, Fc, Italy
Local Institution - 0333
Rozzano, MI, Italy
Istituto Nazionale dei Tumori Regina Elena
Roma, RM, Italy
Local Institution - 0034
Bari, , Italy
ASST Papa Giovanni XXIII - Unita di Oncologia
Bergamo, , Italy
Local Institution - 0326
Candiolo, , Italy
"Azienda Ospedaliero - Universitaria ""Policlinico-Vittorio Emanuele"" - Ospedale Gaspare Rodolico"
Catania, , Italy
Local Institution - 0251
Genova, , Italy
Local Institution
Genova, , Italy
Local Institution - 0108
Meldola, , Italy
Local Institution - 0303
Meldola, , Italy
Fondazione IRCCS istituto Neurologico Carlo Besta;
Milan, , Italy
Local Institution - 0096
Milan, , Italy
Local Institution - 0351
Milan, , Italy
Local Institution
Milan, , Italy
IRCCS Istituto Europeo di Oncologia
Milan, , Italy
Local Institution - 0071
Milan, , Italy
Local Institution
Milan, , Italy
Local Institution - 0327
Modena, , Italy
Istituto Nazionale Tumori - Fondazione Pascale Italy
Napoli, , Italy
Local Institution - 0218
Napoli, , Italy
Local Institution - 0292
Napoli, , Italy
Istituto Oncologico Veneto
Padua, , Italy
AUSL Romagna
Ravenna, , Italy
Local Institution - 0003
Siena, , Italy
Local Institution - 0291
Terni, , Italy
Azienda Ospedaliera Citta della Salute e della Scienza
Torino, , Italy
Local Institution - 0242
Hirosaki-shi, Aomori, Japan
Chiba Cancer Center
Chiba, Chiba, Japan
National Cancer Center Hospital East
Kashiwa-Shi, Chiba, Japan
Ehime Prefectural Central Hospital
Matsuyama, Ehime, Japan
National Hospital Organization Shikoku Cancer Center
Matsuyama, Ehime, Japan
Kyushu University Hospital
Fukuoka, Fukuoka, Japan
Local Institution - 0211
Kobe, Hyōgo, Japan
Local Institution - 0240
Tsukuba, Ibaraki, Japan
Local Institution - 0219
Kanazawa, Ishikawa-ken, Japan
Yokohama City University Medical Center
Yokohama, Kanagawa, Japan
Local Institution - 0222
Natori-shi, Miyagi, Japan
Local Institution - 0230
Niigata, Niigata, Japan
Local Institution - 0214
Sayama, Osaka, Japan
Local Institution - 0212
Takatsuki, Osaka, Japan
Hamamatsu University Hospital
Hamamatsu, Shizuoka, Japan
Tokyo Women's Medical University - Adachi Medical Center
Adachi-Ku, Tokyo, Japan
Institute of Science Tokyo Hospital
Bunkyo-Ku, Tokyo, Japan
Local Institution - 0235
Chuo-ku, Tokyo, Japan
Local Institution - 0217
Koto-Ku, Tokyo, Japan
Local Institution - 0239
Shinjuku, Tokyo, Japan
Local Institution - 0224
Fukuoka, , Japan
Hiroshima University Hospital
Hiroshima, , Japan
Local Institution - 0236
Niigata, , Japan
Local Institution - 0152
León, Guanajuato, Mexico
Local Institution - 0338
Zapopan, Jalisco, Mexico
Local Institution - 0410
Mexico City, Mexico City, Mexico
Local Institution - 0181
Tlalpan, Mexico City, Mexico
Hospital Victoria Medical Center
Morelia, Michoacán, Mexico
Local Institution - 0286
Monterrey, Nuevo León, Mexico
Local Institution - 0354
Monterrey, Nuevo León, Mexico
Local Institution - 0396
Monterrey, Nuevo León, Mexico
Centro de Investigacion Clinica de Oaxaca
Oaxaca City, Oaxaca, Mexico
Local Institution - 0343
Querétaro City, Querétaro, Mexico
Local Institution - 0344
Mexico City, , Mexico
Local Institution - 0346
Mexico City, , Mexico
Local Institution - 0337
Mexico City, , Mexico
Local Institution - 0367
San Luis Potosí City, , Mexico
Local Institution - 0335
Amsterdam, North Holland, Netherlands
Local Institution
Rotterdam, , Netherlands
Auckland City Hospital-Liver Research Unit
Auckland, , New Zealand
Local Institution - 0271
Christchurch, , New Zealand
Local Institution - 0268
Dunedin, , New Zealand
Local Institution - 0269
Tauranga, , New Zealand
Local Institution - 0213
Bergen, , Norway
Local Institution - 0048
Oslo, , Norway
Local Institution - 0179
Santiago de Surco, Lima region, Peru
Local Institution - 0385
Lima, , Peru
Centrum Onkologii im. Prof. Franciszka Lukaszczyka
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Local Institution - 0336
Biała Podlaska, Lublin Voivodeship, Poland
Local Institution - 0414
Olsztyn, Warmian-Masurian Voivodeship, Poland
Local Institution - 0120
Gdansk, , Poland
Wojewodzkie Centrum Onkologii
Gdansk, , Poland
Local Institution - 0377
Krakow, , Poland
Local Institution - 0252
Krakow, , Poland
Local Institution - 0373
Krakow, , Poland
Instytut MSF Sp zoo
Lodz, , Poland
Local Institution - 0118
Lublin, , Poland
Local Institution - 0178
Poznan, , Poland
Wojskowy Instytut Medyczny
Warsaw, , Poland
Local Institution - 0328
Warsaw, , Poland
Local Institution
Warsaw, , Poland
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw, , Poland
Local Institution - 0184
Lisbon, , Portugal
Local Institution - 0177
Lisbon, , Portugal
Local Institution - 0142
Porto, , Portugal
FDI Clinical Research
San Juan, PR, Puerto Rico
Onco Clinic Consult SA
Craiova, Dolj, Romania
Local Institution - 0310
Bucharest, Sector 2, Romania
Institutul Oncologic Bucuresti IOB
Bucharest, , Romania
Local Institution - 0127
Cluj-Napoca, , Romania
Institutul Oncologic Prof. Dr. I. Chiricuta
Cluj-Napoca, , Romania
Local Institution - 0189
Cluj-Napoca, , Romania
Centrul de Oncologie Sf Nectarie
Craiova, , Romania
Local Institution - 0133
Oradea, , Romania
Sc Sigmedical Srl
Suceava, , Romania
Local Institution - 0257
Krasnodar, Krasnodarskiy Kray, Russia
Local Institution - 0256
Krasnoyarsk, , Russia
N.N. Blokhin National Medical Research Center of Oncology
Moscow, , Russia
VitaMed LLC
Moscow, , Russia
Local Institution - 0389
Seongnam-si, Gyeonggi-do, South Korea
Asan Medical Center
Seoul, Songpa-gu, South Korea
National Cancer Center
Gyeonggi-do, , South Korea
Local Institution - 0221
Seongnam-si, , South Korea
Local Institution - 0206
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Local Institution - 0207
Suwon, , South Korea
Local Institution - 0047
Donostia / San Sebastian, Guipuzcoa, Spain
Local Institution - 0287
Majadahonda, Madrid, Spain
Clinica Universidad de Navarra
Pamplona, Navarre, Spain
Local Institution - 0122
A Coruña, , Spain
Local Institution - 0382
A Coruña, , Spain
Local Institution - 0173
Alicante, , Spain
Catalan Institute of Badalona Hospital Germans Trias i Pujol ICO
Badalona, , Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Universitari Vall d Hebron
Barcelona, , Spain
Hospital Clinic de Barcelona
Barcelona, , Spain
Local Institution - 0026
Barcelona, , Spain
Local Institution - 0225
Barcelona, , Spain
Local Institution
Barcelona, , Spain
Local Institution - 0146
Burgos, , Spain
Local Institution - 0144
Granada, , Spain
Local Institution - 0273
Madrid, , Spain
Local Institution - 0357
Madrid, , Spain
Clinica Universidad de Navarra Madrid
Madrid, , Spain
Local Institution - 0008
Madrid, , Spain
Local Institution
Madrid, , Spain
Local Institution - 0027
Madrid, , Spain
Hospital Universitario Fundacion Jimenez Diaz
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Universitario La Paz
Madrid, , Spain
Local Institution
Madrid, , Spain
Hospital Universitario HM Sanchinarro
Madrid, , Spain
Hospital Regional Universitario Carlos Haya
Málaga, , Spain
Local Institution
Santa Cruz de Tenerife, , Spain
Local Institution - 0352
Santander, , Spain
Local Institution - 0274
Seville, , Spain
Local Institution - 0294
Seville, , Spain
Hospital General Universitario de Valencia
Valencia, , Spain
Hospital Universitario y Politecnico de La Fe
Valencia, , Spain
Local Institution
Gothenburg, , Sweden
Local Institution - 0036
Malmo, , Sweden
Local Institution
Umeå, , Sweden
Local Institution - 0119
Basel, , Switzerland
Local Institution - 0403
Sankt Gallen, , Switzerland
UniversitaetsSpital Zuerich - Dermatology
Zurich, , Switzerland
Taichung Veterans General Hospital
Taichung, , Taiwan
Local Institution - 0197
Tainan City, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Taipei Veterans General Hospital TPVGH
Taipei, , Taiwan
Local Institution - 0330
Ankara, , Turkey (Türkiye)
North Middlesex University Hospital
London, Greater London, United Kingdom
University College Hospital
London, Greater London, United Kingdom
Royal Marsden Hospital Sutton
London, Greater London, United Kingdom
Local Institution - 0086
London, Greater London, United Kingdom
The Christie Hospital
Manchester, Greater Manchester, United Kingdom
Local Institution - 0195
Southampton, Hampshire, United Kingdom
Local Institution - 0231
Maidstone, Kent, United Kingdom
East & North Hertfordshire NHS Trust
Northwood, Middlesex, United Kingdom
Local Institution - 0299
Edinburgh, Scotland, United Kingdom
Local Institution - 0259
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
BMS Study Connect Contact http://www.bmsstudyconnect.com/
Role: CONTACT
Phone: 855-907-3286
Email: [email protected]
First line of the email MUST contain NCT# and Site#
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jason Chesney, Site 0059
Role: primary
David Reardon, Site 0082
Role: primary
Saby George, Site 0128
Role: primary
Site 0413
Role: primary
Patrick Ward, Site 0085
Role: primary
Site 0408
Role: primary
Asrar Alahmadi, Site 0103
Role: primary
Samuel Kerr, Site 0400
Role: primary
David Spigel, Site 0130
Role: primary
Site 0415
Role: primary
Ruben Kowalyszyn, Site 0405
Role: primary
Gaston Lucas Martinengo, Site 0407
Role: primary
Felipe Salvador Palazzo, Site 0376
Role: primary
Matias Chacon, Site 0030
Role: primary
Martin Richardet, Site 0349
Role: primary
Georgina Long, Site 0062
Role: primary
Catriona McNeil, Site 0009
Role: primary
Victoria Atkinson, Site 0021
Role: primary
Andrew Hill, Site 0347
Role: primary
Wasek Faisal, Site 0411
Role: primary
Benjamin Brady, Site 0005
Role: primary
Clemens Mayr, Site 0149
Role: primary
Matthias Pinter, Site 0321
Role: primary
Sebahat Ocak, Site 0157
Role: primary
Fabio Franke, Site 0155
Role: primary
Site 0093
Role: primary
Rodrigo Pereira, Site 0113
Role: primary
Carlos Barrios, Site 0331
Role: primary
Site 0399
Role: primary
Olavo Feher, Site 0302
Role: primary
Ariel Kann, Site 0355
Role: primary
Quincy Chu, Site 0111
Role: primary
Marcus Butler, Site 0280
Role: primary
Site 0398
Role: primary
Mauricio Burotto, Site 0101
Role: primary
Mauricio Mahave, Site 0019
Role: primary
Ya-Bing Guo, Site 0383
Role: primary
Yuxian Bai, Site 0317
Role: primary
Min Li, Site 0309
Role: primary
Shanzhi Gu, Site 0316
Role: primary
Wei Li, Site 0307
Role: primary
Ying Cheng, Site 0194
Role: primary
Haichuan Su, Site 0318
Role: primary
Guohong Han, Site 0395
Role: primary
Beili Gao, Site 0223
Role: primary
Xianghua Wu, Site 0305
Role: primary
Enguo Chen, Site 0304
Role: primary
Jianying Zhou, Site 0306
Role: primary
Site 0390
Role: primary
Jindrich Kopecky, Site 0243
Role: primary
Jean-Pierre Bronowicki, Site 0362
Role: primary
Hakim Mahammedi, Site 0345
Role: primary
Coureche Kaderbhai, Site 0109
Role: primary
Julie Charles, Site 0010
Role: primary
Laurent Mortier, Site 0011
Role: primary
Caroline Gaudy, Site 0125
Role: primary
philippe quittet, Site 0182
Role: primary
Gaelle Quereux, Site 0341
Role: primary
Stephane Dalle, Site 0084
Role: primary
Pierre CORNILLON, Site 0401
Role: primary
CHRISTINE ABRAHAM, Site 0392
Role: primary
Caroline Robert, Site 0029
Role: primary
Site 0386
Role: primary
Sebastian Ertl, Site 0402
Role: primary
Matthias Saar, Site 0163
Role: primary
Roland Roelz, Site 0315
Role: primary
Sabine Sell, Site 0080
Role: primary
Helge Bischoff, Site 0148
Role: primary
Uwe Martens, Site 0285
Role: primary
Marc-Oliver Grimm, Site 0216
Role: primary
Michail Liontos, Site 0381
Role: primary
Helen Gogas, Site 0022
Role: primary
Thomas Yau, Site 0339
Role: primary
Jacob Schachter, Site 0052
Role: primary
Angelo Delmonte, Site 0361
Role: primary
Michelangelo Russillo, Site 0033
Role: primary
Barbara Merelli, Site 0002
Role: primary
Jose Hector Soto Parra, Site 0359
Role: primary
Elena Anghileri, Site 0312
Role: primary
Filippo de Marinis, Site 0267
Role: primary
Paolo Antonio Ascierto, Site 0073
Role: primary
Umberto Basso, Site 0067
Role: primary
Stefano Tamberi, Site 0180
Role: primary
Alessia Pellerino, Site 0313
Role: primary
Atsushi Komaru, Site 0409
Role: primary
Toshihiko Doi, Site 0356
Role: primary
Fujimasa Tada, Site 0394
Role: primary
Katsuyoshi Hashine, Site 0397
Role: primary
Takashi Matsumoto, Site 0393
Role: primary
Manabu Morimoto, Site 0368
Role: primary
Yuto Matsushita, Site 0391
Role: primary
Tsunenori Kondo, Site 0406
Role: primary
Shohei Fukuda, Site 0404
Role: primary
Tomokazu Kawaoka, Site 0319
Role: primary
Site 0338
Role: primary
Site 0410
Role: primary
Leticia Vazquez Cortes, Site 0007
Role: primary
Site 0396
Role: primary
Roberto Romero Diaz, Site 0369
Role: primary
Site 0344
Role: primary
Site 0346
Role: primary
Site 0337
Role: primary
Site 0367
Role: primary
Edward Gane, Site 0370
Role: primary
Site 0385
Role: primary
Bogdan Zurawski, Site 0358
Role: primary
Site 0336
Role: primary
Site 0414
Role: primary
Joanna Wojcik-Tomaszewska, Site 0069
Role: primary
Ewa Kalinka, Site 0031
Role: primary
Renata Duchnowska, Site 0132
Role: primary
Dariusz Kowalski, Site 0151
Role: primary
Mirelis Acosta-Rivera, Site 0334
Role: primary
Patricia Visan, Site 0378
Role: primary
Aurelia Alexandru, Site 0129
Role: primary
Tudor Ciuleanu, Site 0135
Role: primary
Michael Schenker, Site 0265
Role: primary
Doina Ganea, Site 0374
Role: primary
Min-Hee Ryu, Site 0322
Role: primary
BoHyun Kim, Site 0320
Role: primary
Tae-You Kim, Site 0324
Role: primary
Ignacio Melero Bermejo, Site 0353
Role: primary
Enric Carcereny, Site 0123
Role: primary
Margarita Majem Tarruella, Site 0384
Role: primary
Eva Munoz, Site 0091
Role: primary
Maria Reig, Site 0323
Role: primary
Ignacio Melero Bermejo, Site 0360
Role: primary
Manuel Domine Gomez, Site 0112
Role: primary
Luis Paz-Ares Rodriguez, Site 0116
Role: primary
Javier De Castro Carpeno, Site 0380
Role: primary
Juan Rodriguez Moreno, Site 0097
Role: primary
María Vanesa Gutierrez Calderon, Site 0192
Role: primary
Alfonso Berrocal, Site 0020
Role: primary
Oscar Juan Vidal, Site 0117
Role: primary
Reinhard Dummer, Site 0083
Role: primary
Teng-Yu Lee, Site 0388
Role: primary
Yu-yun Shao, Site 0412
Role: primary
Yi-Hsiang Huang, Site 0366
Role: primary
Georgios Imseeh, Site 0141
Role: primary
Paul Mulholland, Site 0314
Role: primary
James Larkin, Site 0272
Role: primary
Avinash Gupta, Site 0115
Role: primary
Paul Nathan, Site 0161
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
BMS Clinical Trial Information
BMS Clinical Trial Patient Recruiting
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-004362-34
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
CA209-8TT
Identifier Type: -
Identifier Source: org_study_id